Literature DB >> 8913723

Comparative allelotype of early and advanced stage non-small cell lung carcinomas.

M Shiseki1, T Kohno, J Adachi, T Okazaki, T Otsuka, H Mizoguchi, M Noguchi, S Hirohashi, J Yokota.   

Abstract

To identify chromosomal loci of tumor suppressor genes involved in the genesis and progression of non-small cell lung carcinoma (NSCLC), comparative allelotype analysis was performed in 23 stage I primary lung tumors and in 22 metastatic lung tumors to the brain. In total, 84 loci on all 22 autosomal chromosomes were examined for loss of heterozygosity (LOH) by restriction fragment length polymorphism (RFLP) analysis with 40 polymorphic DNA probes and polymerase chain reaction (PCR)-LOH analysis of 44 polymorphic loci. LOH on chromosome arms 3p, 13q, and 17p was detected frequently (> 60%) in both stage I primary lung tumors and brain metastases, whereas the incidence of LOH on chromosome arms 2q, 5q, 9p, 12q, 18q, and 22q was more than 60% only in brain metastases. In particular, the incidence of LOH on chromosome arms 2q, 9p, 18q, and 22q in brain metastases was significantly higher than that in stage I primary lung tumors (P < 0.05). These results indicate that tumor suppressor genes on chromosome arms 3p, 13q, and 17p are involved in the genesis of NSCLC, whereas those on several chromosome arms, especially on 2q, 9p, 18q and 22q, play an important role in the progression of NSCLC.

Entities:  

Mesh:

Year:  1996        PMID: 8913723     DOI: 10.1002/(SICI)1098-2264(199610)17:2<71::AID-GCC1>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  Molecular determinants of lung cancer metastasis to the central nervous system.

Authors:  Timothy G Whitsett; Landon J Inge; Harshil D Dhruv; Philip Y Cheung; Glen J Weiss; Ross M Bremner; Jeffrey A Winkles; Nhan L Tran
Journal:  Transl Lung Cancer Res       Date:  2013-08

Review 2.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  Topographical distributions of allelic loss in individual non-small-cell lung cancers.

Authors:  Y Yatabe; H Konishi; T Mitsudomi; S Nakamura; T Takahashi
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Mutation and expression of the DCC gene in human lung cancer.

Authors:  T Kohno; T Sato; S Takakura; K Takei; K Inoue; M Nishioka; J Yokota
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

5.  A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.

Authors:  Takashi Kohno; Ayaka Otsuka; Luc Girard; Masanori Sato; Reika Iwakawa; Hideaki Ogiwara; Montse Sanchez-Cespedes; John D Minna; Jun Yokota
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

6.  Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.

Authors:  Matteo Fassan; Domenico D'Arca; Juraj Letko; Andrea Vecchione; Marina P Gardiman; Peter McCue; Bernadette Wildemore; Massimo Rugge; Dolores Shupp-Byrne; Leonard G Gomella; Andrea Morrione; Renato V Iozzo; Raffaele Baffa
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

7.  Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.

Authors:  Xingli Zhuo; Lan Chen; Zongwei Lai; Jiansheng Liu; Shengjun Li; Ahu Hu; Yuansheng Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer.

Authors:  A Vecchione; M Fassan; V Anesti; A Morrione; S Goldoni; G Baldassarre; D Byrne; D D'Arca; J P Palazzo; J Lloyd; L Scorrano; L G Gomella; R V Iozzo; R Baffa
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.